272 related articles for article (PubMed ID: 32335023)
1. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
[TBL] [Abstract][Full Text] [Related]
2. Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents.
Boon M; Claes I; Havermans T; Fornés-Ferrer V; Calvo-Lerma J; Asseiceira I; Bulfamante A; Garriga M; Masip E; Woodcock S; Walet S; Barreto C; Colombo C; Crespo P; Van der Wiel E; Hulst J; Martinez-Barona S; Nobili R; Pereira L; Ruperto M; Vicente S; De Boeck K; Ribes-Koninckx C;
PLoS One; 2019; 14(12):e0225004. PubMed ID: 31860639
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.
Calvo-Lerma J; Boon M; Colombo C; de Koning B; Asseiceira I; Garriga M; Roca M; Claes I; Bulfamante A; Walet S; Pereira L; Ruperto M; Masip E; Asensio-Grau A; Giana A; Affourtit P; Heredia A; Vicente S; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
J Cyst Fibros; 2021 Sep; 20(5):e33-e39. PubMed ID: 33279468
[TBL] [Abstract][Full Text] [Related]
4. Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF.
Raun AMT; Brekke G; Mølgaard C; Jaudszus A; Mainz JG; Pressler T; Skov M
Acta Paediatr; 2022 Feb; 111(2):432-439. PubMed ID: 34626004
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines.
Calvo-Lerma J; Hulst JM; Asseiceira I; Claes I; Garriga M; Colombo C; Fornés V; Woodcock S; Martins T; Boon M; Ruperto M; Walet S; Speziali C; Witters P; Masip E; Barreto C; de Boeck K; Ribes-Koninckx C;
J Cyst Fibros; 2017 Jul; 16(4):510-518. PubMed ID: 28320633
[TBL] [Abstract][Full Text] [Related]
6. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
7. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C
United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
[TBL] [Abstract][Full Text] [Related]
9. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
10. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.
McDonald CM; Reid EK; Pohl JF; Yuzyuk TK; Padula LM; Vavrina K; Altman K
Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S57-S77. PubMed ID: 38429959
[TBL] [Abstract][Full Text] [Related]
12. Community Perspective on Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
Borowitz D; Brooks JF; Aliaj E; Gallotto D
J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):e94-e97. PubMed ID: 36070542
[TBL] [Abstract][Full Text] [Related]
13. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal pathophysiology and nutrition in cystic fibrosis.
Ratchford TL; Teckman JH; Patel DR
Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):853-862. PubMed ID: 30019967
[TBL] [Abstract][Full Text] [Related]
15. Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.
Schall JI; Bentley T; Stallings VA
J Pediatr Gastroenterol Nutr; 2006 Nov; 43(5):651-9. PubMed ID: 17130744
[TBL] [Abstract][Full Text] [Related]
16. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
18. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of pancreatic exocrine insufficiency.
Dominguez-Muñoz JE
Curr Opin Gastroenterol; 2018 Sep; 34(5):349-354. PubMed ID: 29889111
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation.
Rudolf I; Pieper K; Nolte H; Junge S; Dopfer C; Sauer-Heilborn A; Ringshausen FC; Tümmler B; von Jan U; Albrecht UV; Fuge J; Hansen G; Dittrich AM
JMIR Mhealth Uhealth; 2019 Nov; 7(11):e12442. PubMed ID: 31750841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
